Boehringer Ingelheim Vetmedica, Inc. (BIVI), announces the 2013 recipients of its annual Advancement in PRRS Research Awards. This year, BIVI awarded $75,000 to support three separate studies by independent swine researchers and practitioners in their investigations of novel ways to diagnose, control and eliminate this costly swine disease.
US - Controlling swine diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Associated Disease (PCV2) and Mycoplasma pneumonia (M. hyo) is one of the the key challenges for producers and veterinarians. During the 2012 World Pork Expo, swine experts discussed the impacts of these diseases, the latest research and effective ways to manage respiratory diseases on modern production farms.
US - The research driven pharmaceutical company Boehringer Ingelheim will expand its global animal health vaccines business. With the completion of a series of major investments at the US site in St. Joseph, Missouri, the company will further enhance its position in the development and supply of vaccines against the most important diseases of pigs.
Boehringer Ingelheim yesterday announced the expansion of its Animal Health business in China. One of the major moves is the opening of the Asian Veterinary Research & Development (R&D) Center in Zhangjiang, Shanghai.
Get the latest news on Swine Health Subscribe to our newsletter